|
|
Journal of Korean Neurosurgical Society 2001;30(1): 5-11. |
The Role of Basic Fibroblast Growth Factor in Moyamoya Disease. |
Dong Seok Kim, Joong Uhn Choi, Se Hyuk Kim, Kook Hee Yang, Hyeun Sook Kim |
1Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea. 2Department of Clinical Pathology, Yonsei University College of Medicine, Seoul, Korea. 3Brain Research Institute Yonsei University College of Medicine, Seoul, Korea. |
|
|
|
ABSTRACT |
OBJECTIVE S AND OMPORTANCE: The present study investigated the levels of basic fibroblast growth factor(bFGF) in the CSF of patients with moyamoya disease and its clinical significance. METHODS The levels of bFGF in CSF, taken from 26 hemispheres of 14 moyamoya patients and 20 patients without vascular anomaly(control group), were measured by an enzyme-linked immunosorbent assay. We analyzed the correlation between the level of bFGF and the clinical factors such as age, onset pattern, development of neovascularization, and cerebral circulation. RESULTS The CSF of moyamoya patients contained a high concentration of bFGF to a significant extent. The bFGF level was apparently elevated in the patients in whom neovascularization from indirect revascularization, such as modified encephalo-duro-arterio-synangiosis(EDAS) was well developed. A linear correlation between the values of bFGF and clinical progression was noted. CONCLUSIONS The elevation of bFGF in moyamoya disease seems to be specific. Clinically, the bFGF level may be considered a useful indicator to predict the efficacy of indirect revascularization. |
Key Words:
Angiogenesis; Basic fibroblast growth factor; Encephalo-duro-arterio-synangiosis; Moyamoya disease |
|
|
|